EUVIMEDEUVIMED entdecken
Multizentrische Studie

Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries

Asiiat Alieva, Alessia Di Costanzo, Marta Gazzotti, Olga Reutova, Elena Usova, Viktoria Bakaleiko, Marcello Arca, Laura D'Erasmo, Fabio Pellegatta, Federica Galimberti, Elena Olmastroni, Alberico L Catapano und 1 weitere

European Journal of Internal Medicine · 2024

DOI: 10.1016/j.ejim.2024.01.010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Internal Medicine, 2024. Verfasst von Asiiat Alieva und 12 weiteren Autor:innen. Beteiligte Einrichtung: Almazov National Medical Research Centre, Saint Petersburg, Russia. Electronic address: asiiat.alieva.s@gmail.com. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Cholesterol, LDL, Genetic Testing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Familial hypercholesterolemia (FH) is a genetically determined monogenic disorder of predominantly autosomal dominant inheritance. A number of studies on differences in the genetic profile of patients with FH have demonstrated the importance of a more substantive evaluation of genetic features. The aim of this study was to evaluate the genetic profile of patients with clinical FH among Italian and Russian patients. METHODS: We included 144 Italian and 79 Russian FH patients; clinical diagnosis was based on the same criteria. Patients were divided in: positive to genetic test (one causative variant), inconclusive (only variants of uncertain clinical significance [VUS]), and negative (with likely benign/benign variants, heterozygous variants in LDLRAP1 gene, or without causative variants). RESULTS: The genetic test was positive in 76.4 % of the Italian patients and in 49.4 % of the Russian patients. The presence of VUS alone was detected in 7.6 % and in 19.0 % (p < 0.001), respectively. Among patients with positive genetic diagnosis, pre-treatment LDL-C levels were higher in the Russian cohort (353.5 ± 111.3 vs. 302.7 ± 52.1 mg/dL, p = 0.009), as well as the percentage of treated patients (53.8 % vs. 14.5 %, p < 0.001) and the prevalence of premature coronary heart disease (12.8 % vs. 3.6 %, p = 0.039). Among patients carrying only VUS, mean pre-treatment LDL-C levels were similar between the cohorts (299.5 ± 68.1 vs. 295.3 ± 46.8 mg/dL, p = 0.863). Among pathogenic/likely pathogenic variants and VUS, only 5 % and 4 % was shared between the two cohorts, respectively. CONCLUSION: The genetic background of patients clinically diagnosed with FH in two different countries is characterized by high variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IICholesterol, LDLGenetic TestingHumansFemaleMaleItalyMiddle AgedAdultRussiaGenetic HeterogeneityAdaptor Proteins, Signal TransducingAgedMutation

Stichwörter der Autor:innen

Familial hypercholesterolemiaGenetic heterogeneityMolecular diagnosisPhenotypic expressionVariants of uncertain clinical significance

Substanzen

Cholesterol, LDLLDLRAP1 protein, humanAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Almazov National Medical Research Centre, Saint Petersburg, Russia. Electronic address: asiiat.alieva.s@gmail.com.
  • Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • SISA FOUNDATION, Milan, Italy.
  • Almazov National Medical Research Centre, Saint Petersburg, Russia.
  • IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
  • IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy; Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences (DisFeB), University of Milan, Milan, Italy.

Zitieren

APA

Alieva, A., Di Costanzo, A., Gazzotti, M., Reutova, O., Usova, E., Bakaleiko, V., Arca, M., D'Erasmo, L., Pellegatta, F., Galimberti, F., Olmastroni, E., Catapano, A. L., & Casula, M. (2024). Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2024.01.010

Vancouver

Alieva A, Di Costanzo A, Gazzotti M, Reutova O, Usova E, Bakaleiko V, et al. Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries. European Journal of Internal Medicine. 2024. doi:10.1016/j.ejim.2024.01.010

BibTeX
@article{Alieva2024,
  author = {Alieva, Asiiat and Di Costanzo, Alessia and Gazzotti, Marta and Reutova, Olga and Usova, Elena and Bakaleiko, Viktoria and Arca, Marcello and D'Erasmo, Laura and Pellegatta, Fabio and Galimberti, Federica and Olmastroni, Elena and Catapano, Alberico L and Casula, Manuela},
  title = {Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries},
  journal = {European Journal of Internal Medicine},
  year = {2024},
  doi = {10.1016/j.ejim.2024.01.010}
}
Kostenlos starten →